Among modern cancer therapies, immune checkpoint inhibitors (ICI) are among the most successful treatment methods. These ...
According to a Phase I study led by researchers at The University of Texas MD Anderson Cancer Center, published today in ...
Stocktwits on MSN
IBRX garners retail attention on positive update in immunotherapy for lung cancer patients
The company said that responding patients lived longer overall, with a median survival of 16.2 months. ・The data come from ...
BOISE, ID, UNITED STATES, November 20, 2025 /EINPresswire.com/ -- In recent years, immunotherapy checkpoint inhibitors have transformed from an emerging scientific ...
GlobalData on MSN
ImmunityBio’s Anktiva shows success as combo treatment in NSCLC
Anktiva plus checkpoint inhibitor therapy demonstrated statistically significant immune restoration across two clinical ...
Oncologists have achieved some immune system responses in patients with pancreatic cancers using various combinations of ...
The deletion of two cancer genes, CHD1 and MAP3K7, improves how well tumors respond to cancer immunotherapy and could be used ...
In attempt to assess treatment patterns in advanced gastric cancer across racial and ethnic groups throughout the U.S., ...
In a Jan. 13th installation of the Stanford Cancer Institute’s “Breakthroughs in Cancer” lecture series, Lawrence Fong ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback